Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Am J Health Syst Pharm ; 66(13): 1218-23, 2009 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-19535661

RESUMEN

PURPOSE: The clinical effectiveness of a group-visit model versus individual point-of-care visits is compared by International Normalized Ratio (INR) monitoring in a pharmacist-managed anticoagulation clinic. METHODS: This study was a prospective, randomized, repeated-measures, two-group, intention-to-treat comparison and survey at a pharmacist-managed anticoagulation clinic in a managed-care ambulatory care setting. Patients were eligible for this study if they were taking warfarin therapy for at least 30 days, had a goal INR range, and provided consent. At a routine point-of-care visit, eligible patients were randomly invited to participate in group visits. The number of visits and INR values were documented prospectively for both groups during the 16-week study period. RESULTS: Of the 45 patients who consented and enrolled in group visits, 28 patients participated for the 16-week study period. The control group included 108 patients seen by a pharmacist for individual anticoagulation appointments. No significant difference in the percentage of INR values within the therapeutic range was detected between patients in the group-visit model versus patients receiving individual visits (59% versus 56.6%, respectively; p = 0.536). Seventy-three percent of INR values for patients who attended group visits were within +/- 0.2 of the desired INR range compared with 71.9% of those in the control group ( p = 0.994). In addition, 79% of group-visit patients were within the therapeutic range at their last clinic visit compared with 67% of patients who attended individual appointments (p = 0.225). Group visits were preferred by 51% (n = 38) of patients who completed the satisfaction survey. Of the 92 patients who declined group-visit participation, 36% indicated that the time of day that group visits were offered was inconvenient. There were no thromboembolic or hemorrhagic events documented in either group during the study period. CONCLUSION: Group visits in a pharmacist-managed anticoagulation clinic may provide a safe and effective alternative to individual appointments.


Asunto(s)
Anticoagulantes/uso terapéutico , Monitoreo de Drogas/métodos , Relación Normalizada Internacional/métodos , Warfarina/uso terapéutico , Adulto , Anciano , Anciano de 80 o más Años , Instituciones de Atención Ambulatoria/organización & administración , Anticoagulantes/efectos adversos , Anticoagulantes/farmacología , Femenino , Humanos , Masculino , Programas Controlados de Atención en Salud/organización & administración , Persona de Mediana Edad , Satisfacción del Paciente , Servicios Farmacéuticos/organización & administración , Farmacéuticos/organización & administración , Rol Profesional , Estudios Prospectivos , Warfarina/efectos adversos , Warfarina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...